[Adrenal cortex scintigraphy with and without dexamethasone suppression in the study of primary aldosteronism].
Milà López
M
M
Servei de Medicina Nuclear, Hospital Universitari Vall d'Hebron, Barcelona.
Castell-Conesa
J
J
Pifarré Montaner
P
P
Lorenzo Bosquet
C
C
García-Burillo
A
A
Porta Biosca
F
F
Roca Bielsa
I
I
D015071:19-Iodocholesterol / Q000031:analogs & derivatives*; D000236:Adenoma / Q000150:complications / Q000000981:diagnostic imaging*; D000302:Adrenal Cortex / Q000000981:diagnostic imaging* / Q000187:drug effects / Q000473:pathology; D000306:Adrenal Cortex Neoplasms / Q000150:complications / Q000000981:diagnostic imaging*; D000328:Adult; D000368:Aged; D003907:Dexamethasone / Q000494:pharmacology; D005189:False Positive Reactions; D005260:Female; D006801:Humans; D006929:Hyperaldosteronism / Q000000981:diagnostic imaging* / Q000209:etiology; D006965:Hyperplasia; D007457:Iodine Radioisotopes; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D012189:Retrospective Studies; D012680:Sensitivity and Specificity
C023033:I-norcholesterol; D007457:Iodine Radioisotopes; D019275:Radiopharmaceuticals; D015071:19-Iodocholesterol; D003907:Dexamethasone
Gammagrafía suprarrenal cortical con frenación y supresión de la frenación con dexametasona en el estudio del hiperaldosteronismo primario.